Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Regul Toxicol Pharmacol ; 114: 104656, 2020 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-32437818

RESUMO

Additional non-animal methods are urgently needed to meet regulatory and animal welfare goals. TTC is a broadly used risk assessment tool. TTC based on external dose has limited utility for multi-route exposure and some types of structure activity relationship assessments. An internal TTC (iTTC), where thresholds are based on blood concentration, would extend the applicability of TTC. While work is on-going to develop robust iTTC thresholds, we propose an interim conservative iTTC. Specifically, an interim iTTC of 1 µM, supported by the published experience of the pharmaceutical industry, a literature review of non-drug chemical/receptor interactions, and analysis of ToxCast™ data. ToxCast™ data were used to explore activity versus the 1 µM interim iTTC and recommendations for the analysis and interpretation of HTS data. Test concentration-based points of departure were classified to identify quality of fit to the Hill Model. We identified, for exclusion from the approach, estrogen receptor and androgen receptor targets as potent chemical/receptor interactions potentially associated with low dose exposure to non-pharmaceutical active ingredients in addition to the original TTC exclusions. With these exclusions, we conclude that a 1 µM plasma concentration is unlikely to be associated with significant biological effects from chemicals not intentionally designed for biological activity.


Assuntos
Ácido Acético/efeitos adversos , Aspirina/efeitos adversos , Automação , Receptores Androgênicos/metabolismo , Ácido Salicílico/efeitos adversos , Ácido Acético/química , Ácido Acético/metabolismo , Animais , Aspirina/química , Aspirina/metabolismo , Relação Dose-Resposta a Droga , Humanos , Estrutura Molecular , Nível de Efeito Adverso não Observado , Receptores Androgênicos/química , Medição de Risco , Ácido Salicílico/química , Ácido Salicílico/metabolismo , Relação Estrutura-Atividade
2.
Regul Toxicol Pharmacol ; 103: 63-72, 2019 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-30653989

RESUMO

The Threshold of Toxicological Concern (TTC) is an important risk assessment tool which establishes acceptable low-level exposure values to be applied to chemicals with limited toxicological data. One of the logical next steps in the continued evolution of TTC is to develop this concept further so that it is representative of internal exposures (TTC based on plasma concentration). An internal TTC (iTTC) would provide threshold values that could be utilized in exposure-based safety assessments. As part of a Cosmetics Europe (CosEu) research program, CosEu has initiated a project that is working towards the development of iTTCs that can be used for the human safety assessment. Knowing that the development of an iTTC is an ambitious and broad-spanning topic, CosEu organized a Working Group comprised a balance of multiple stakeholders (cosmetics and chemical industries, the EPA and JRC and academia) with relevant experience and expertise and workshop to critically evaluate the requirements to establish an iTTC. Outcomes from the workshop included an evaluation on the current state of the science for iTTC, the overall iTTC strategy, selection of chemical databases, capture and curation of chemical information, ADME and repeat dose data, expected challenges, as well as next steps and ongoing work.


Assuntos
Cosméticos/toxicidade , Animais , Cosméticos/efeitos adversos , Cosméticos/metabolismo , Europa (Continente) , Humanos , Medição de Risco
3.
Contact Dermatitis ; 49(3): 140-7, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-14678210

RESUMO

The quantitative risk assessment (QRA) paradigm has been extended to evaluating the risk of induction of allergic contact dermatitis from consumer products. Sensitization QRA compares product-related, topical exposures to a safe benchmark, the sensitization reference dose. The latter is based on an experimentally or clinically determined 'no observable adverse effect level' (NOAEL) and further refined by incorporating 'sensitization uncertainty factors' (SUFs) that address variables not adequately reflected in the data from which the threshold NOAEL was derived. A critical area of uncertainty for the risk assessment of oral care or feminine hygiene products is the extrapolation from skin to mucosal exposures. Most sensitization data are derived from skin contact, but the permeability of vulvovaginal and oral mucosae is greater than that of keratinized skin. Consequently, the QRA for some personal products that are exposed to mucosal tissue may require the use of more conservative SUFs. This article reviews the scientific basis for SUFs applied to topical exposure to vulvovaginal and oral mucosae. We propose a 20-fold range in the default uncertainty factor used in the contact sensitization QRA when extrapolating from data derived from the skin to situations involving exposure to non-keratinized mucosal tissue.


Assuntos
Alérgenos/toxicidade , Dermatite Alérgica de Contato/epidemiologia , Dermatite Alérgica de Contato/etiologia , Mucosa/efeitos dos fármacos , Medição de Risco/métodos , Incerteza , Benchmarking , Interpretação Estatística de Dados , Feminino , Humanos , Mucosa Bucal/efeitos dos fármacos , Nível de Efeito Adverso não Observado , Vulva/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA